Pfizer Warns of Skin, Heart Risks From Bextra
557597
Oct. 15, 2004 -- Bextra -- one of two US approved Vioxx sister drugs -- may cause rare skin and heart side effects, its manufacturer today warned doctors.
446964
WASHINGTON (CBS.MW) -- The US Food and Drug Administration said on Thursday that Pfizer&#39;s new pain drug Bextra will carry a labeled warning about a risk of cardiac and blood-clotting problems.
422988
The withdrawal of Vioxx from the market in September and more recent concerns about its cousin Bextra have raised safety questions about this entire class of painkillers
64597
Pfizer Inc. on Friday reported an increased risk of heart problems among patients taking high doses of its popular painkiller and arthritis drug Celebrex.
507272
Pfizer Inc. said Friday that it will provide health-care professionals with additional information about its Bextra arthritis drug and that it will conduct further studies to confirm the drug&#39;s long-term cardiovascular safety record.
19437
Recent studies have suggested that Celebrex and Bextra may increase the risk of heart attack and stroke.
626420
Pfizer Inc. said on Wednesday that a  report in The New York Times draws "unsubstantiated  conclusions" about the safety of its painkiller Bextra.
80575
Drugmaker Pfizer Inc. is in talks with  regulators over a likely change to arthritis drug Bextra's  label to carry the strictest possible warning alerting doctors  of the risk of a potentially deadly skin reaction, the company  said in a regulatory filing.
206395
Pfizer Inc. PFE.N on Friday said two  small clinical trials showed heart bypass surgery patients  taking Bextra, an anti-inflammatory in the same class as the  recently withdrawn drug Vioxx, had an increased risk of stroke  and heart attack.
16125
The Food and Drug Administration yesterday ordered a review of all prevention studies involving drugs such as Celebrex and Bextra, which have been associated with increased risk of heart problems. The agency also urged the public to limit use of over-the-counter pain medications.
352014
Pfizer Inc. will warn doctors that its Bextra painkiller, which is in the same group of drugs as Merck &amp; Co.&#39;s withdrawn Vioxx, is linked to an elevated risk of blood clots, heart attacks and strokes in cardiac-surgery patients.
41032
St Petersburg - There&#39;s a new warning out about another popular pain pill that could be dangerous for your heart. Drug maker Pfizer says recent studies show an increased risk of heart problems in people who take Celebrex.
594114
Drugmaker Pfizer Inc. is in talks with  regulators over a likely change to arthritis drug Bextra's  label to carry a strict warning alerting doctors of the risk of  a potentially deadly skin reaction, the company said in a  regulatory filing.
102866
A study suggesting arthritis drug Bextra doubles patients&#39; heart attack and stroke risks drew a sharp rebuttal Wednesday from the drug&#39;s maker, Pfizer (PFE), as its stock price dipped.
34442
Pfizer is the latest drug maker to warn that a product already on the market may pose serious health risks. It took outrage from activists in September to get the Food and Drug Administration to require warning
443157
U.S. health officials Thursday called on doctors to limit prescribing Pfizer Inc. painkillers Celebrex and Bextra in light of recent evidence that they may increase the risk of heart attack and stroke.
176679
The government is warning of potential heart problems associated with the use of the painkiller Bextra in people who have recently had heart bypass surgery.